The Anti-Mullerian hormone and ovarian cancer

ISSN： 1460-2369

Source： Human Reproduction Update, Vol.13, Iss.3, 2007-06, pp. : 265-273

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Menopausal hormone therapy and risk of ovarian cancer: systematic review and meta-analysis

By Greiser Claudia M. Greiser Eberhard M. Dren Martina

Human Reproduction Update, Vol. 13, Iss. 5, 2007-06 ,pp. : 453-463

Oxford University Press

Access to resources Recommend Favorite

Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity

By Gottschalk Nina Kimmig Rainer Lang Stephan Singh Mahavir Brandau Sven

International Journal of Molecular Sciences, Vol. 13, Iss. 9, 2012-09 ,pp. : 12000-12016

MDPI

Access to resources Recommend Favorite

A Blockade of IGF Signaling Sensitizes Human Ovarian Cancer Cells to the Anthelmintic Niclosamide-Induced Anti-Proliferative and Anticancer Activities

Cellular Physiology and Biochemistry, Vol. 39, Iss. 3, 2016-08 ,pp. : 871-888

Karger

Access to resources Recommend Favorite

HDAC6 and Ovarian Cancer

By Haakenson Joshua Zhang Xiaohong

International Journal of Molecular Sciences, Vol. 14, Iss. 5, 2013-05 ,pp. : 9514-9535

MDPI

Access to resources Recommend Favorite

Chemokine Receptors in Epithelial Ovarian Cancer

By Muralidhar Goda G. Barbolina Maria V.

International Journal of Molecular Sciences, Vol. 15, Iss. 1, 2013-12 ,pp. : 361-376

MDPI

Access to resources Recommend Favorite